206 related articles for article (PubMed ID: 12944350)
1. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.
Sekine Y; Minabe Y; Ouchi Y; Takei N; Iyo M; Nakamura K; Suzuki K; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Mori N
Am J Psychiatry; 2003 Sep; 160(9):1699-701. PubMed ID: 12944350
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
Sekine Y; Iyo M; Ouchi Y; Matsunaga T; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Takei N; Mori N
Am J Psychiatry; 2001 Aug; 158(8):1206-14. PubMed ID: 11481152
[TBL] [Abstract][Full Text] [Related]
3. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.
Volkow ND; Chang L; Wang GJ; Fowler JS; Ding YS; Sedler M; Logan J; Franceschi D; Gatley J; Hitzemann R; Gifford A; Wong C; Pappas N
Am J Psychiatry; 2001 Dec; 158(12):2015-21. PubMed ID: 11729018
[TBL] [Abstract][Full Text] [Related]
4. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
McCann UD; Wong DF; Yokoi F; Villemagne V; Dannals RF; Ricaurte GA
J Neurosci; 1998 Oct; 18(20):8417-22. PubMed ID: 9763484
[TBL] [Abstract][Full Text] [Related]
5. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography.
Ouchi Y; Yoshikawa E; Okada H; Futatsubashi M; Sekine Y; Iyo M; Sakamoto M
Ann Neurol; 1999 May; 45(5):601-10. PubMed ID: 10319882
[TBL] [Abstract][Full Text] [Related]
6. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.
Moeller SJ; Okita K; Robertson CL; Ballard ME; Konova AB; Goldstein RZ; Mandelkern MA; London ED
Neuropsychopharmacology; 2018 Mar; 43(4):751-760. PubMed ID: 28664927
[TBL] [Abstract][Full Text] [Related]
7. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers.
Sekine Y; Ouchi Y; Takei N; Yoshikawa E; Nakamura K; Futatsubashi M; Okada H; Minabe Y; Suzuki K; Iwata Y; Tsuchiya KJ; Tsukada H; Iyo M; Mori N
Arch Gen Psychiatry; 2006 Jan; 63(1):90-100. PubMed ID: 16389202
[TBL] [Abstract][Full Text] [Related]
8. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.
Volkow ND; Chang L; Wang GJ; Fowler JS; Leonido-Yee M; Franceschi D; Sedler MJ; Gatley SJ; Hitzemann R; Ding YS; Logan J; Wong C; Miller EN
Am J Psychiatry; 2001 Mar; 158(3):377-82. PubMed ID: 11229977
[TBL] [Abstract][Full Text] [Related]
9. Long-term methamphetamine-induced decreases of [(11)C]WIN 35,428 binding in striatum are reduced by GDNF: PET studies in the vervet monkey.
Melega WP; Lacan G; Desalles AA; Phelps ME
Synapse; 2000 Mar; 35(4):243-9. PubMed ID: 10657033
[TBL] [Abstract][Full Text] [Related]
10. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.
McCann UD; Kuwabara H; Kumar A; Palermo M; Abbey R; Brasic J; Ye W; Alexander M; Dannals RF; Wong DF; Ricaurte GA
Synapse; 2008 Feb; 62(2):91-100. PubMed ID: 17992686
[TBL] [Abstract][Full Text] [Related]
11. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.
Volkow ND; Chang L; Wang GJ; Fowler JS; Franceschi D; Sedler M; Gatley SJ; Miller E; Hitzemann R; Ding YS; Logan J
J Neurosci; 2001 Dec; 21(23):9414-8. PubMed ID: 11717374
[TBL] [Abstract][Full Text] [Related]
12. Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.
Ashok AH; Mizuno Y; Volkow ND; Howes OD
JAMA Psychiatry; 2017 May; 74(5):511-519. PubMed ID: 28297025
[TBL] [Abstract][Full Text] [Related]
13. Neuromechanism of developing methamphetamine psychosis: a neuroimaging study.
Iyo M; Sekine Y; Mori N
Ann N Y Acad Sci; 2004 Oct; 1025():288-95. PubMed ID: 15542729
[TBL] [Abstract][Full Text] [Related]
14. The orbitofrontal cortex in methamphetamine addiction: involvement in fear.
Goldstein RZ; Volkow ND; Chang L; Wang GJ; Fowler JS; Depue RA; Gur RC
Neuroreport; 2002 Dec; 13(17):2253-7. PubMed ID: 12488806
[TBL] [Abstract][Full Text] [Related]
15. Brain serotonin transporter in human methamphetamine users.
Kish SJ; Fitzmaurice PS; Boileau I; Schmunk GA; Ang LC; Furukawa Y; Chang LJ; Wickham DJ; Sherwin A; Tong J
Psychopharmacology (Berl); 2009 Mar; 202(4):649-61. PubMed ID: 18841348
[TBL] [Abstract][Full Text] [Related]
16. Striatal dopaminergic abnormalities in human cocaine users.
Little KY; Zhang L; Desmond T; Frey KA; Dalack GW; Cassin BJ
Am J Psychiatry; 1999 Feb; 156(2):238-45. PubMed ID: 9989560
[TBL] [Abstract][Full Text] [Related]
17. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.
London ED; Simon SL; Berman SM; Mandelkern MA; Lichtman AM; Bramen J; Shinn AK; Miotto K; Learn J; Dong Y; Matochik JA; Kurian V; Newton T; Woods R; Rawson R; Ling W
Arch Gen Psychiatry; 2004 Jan; 61(1):73-84. PubMed ID: 14706946
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects.
Paulus MP; Hozack NE; Zauscher BE; Frank L; Brown GG; Braff DL; Schuckit MA
Neuropsychopharmacology; 2002 Jan; 26(1):53-63. PubMed ID: 11751032
[TBL] [Abstract][Full Text] [Related]
19. Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography.
Laakso A; Vilkman H; Alakare B; Haaparanta M; Bergman J; Solin O; Peurasaari J; Räkköläinen V; Syvälahti E; Hietala J
Am J Psychiatry; 2000 Feb; 157(2):269-71. PubMed ID: 10671399
[TBL] [Abstract][Full Text] [Related]
20. Effects of repeated cocaine on the release and clearance of dopamine within the rat medial prefrontal cortex.
Williams JM; Steketee JD
Synapse; 2005 Feb; 55(2):98-109. PubMed ID: 15529334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
